Kathrin Schmeisser

Kathrin Schmeisser

Auto-generated profile, based on publicly available information

Kathrin Schmeisser

Max Planck Institute of Molecular Cell Biology and Genetics 5 , Dresden 01307, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
KSKathrin Schmeisser
Kathrin Schmeisser
DKDamla Kaptan
Damla Kaptan
BRBharath Kumar Raghuraman
Bharath Kumar Raghuraman
Andrej ShevchenkoAndrej Shevchenko
Andrej Shevchenko
JRJonathan Rodenfels
Jonathan Rodenfels
TKTeymuras V. Kurzchalia
Teymuras V. Kurzchalia
Recovery from the quiescent developmental stage called dauer is an essential process in C. elegans and provides an excellent model to understand how metabolic transitions contribute to developmental plasticity. Here we show that cholesterol bound to the small secreted proteins SCL-12 or SCL-13 is sequestered in the gut lumen during the dauer state. Upon recovery from dauer, bound cholesterol undergoes endocytosis into lysosomes of intestinal cells, where SCL-12 and SCL-13 are degraded and cholesterol is released. Free cholesterol activates mTORC1 and is used for the production of dafachronic acids. This leads to promotion of protein synthesis and growth, and a metabolic switch at the transcriptional level. Thus, mobilization of sequestered cholesterol stores is the key event for transition from quiescence to growth, and cholesterol is the major signaling molecule in this process.

15 June 2024 in Development
Verified
Journal Article
Closed access
AGAlexandra M. Garfinkel
Alexandra M. Garfinkel
EIEfe Ilker
Efe Ilker
HMHidenobu Miyazawa
Hidenobu Miyazawa
KSKathrin Schmeisser
Kathrin Schmeisser
JTJason Tennessen
Jason Tennessen
The field of developmental metabolism is experiencing a technological revolution that is opening entirely new fields of inquiry. Advances in metabolomics, small-molecule sensors, single-cell RNA sequencing and computational modeling present new opportunities for exploring cell-specific and tissue-specific metabolic networks, interorgan metabolic communication, and gene-by-metabolite interactions in time and space. Together, these advances not only present a means by which developmental biologists can tackle questions that have challenged the field for centuries, but also present young scientists with opportunities to define new areas of inquiry. These emerging frontiers of developmental metabolism were at the center of a highly interactive 2023 EMBO workshop ‘Developmental metabolism: flows of energy, matter, and information’. Here, we summarize key discussions from this forum, emphasizing modern developmental biology's challenges and opportunities.

26 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KSKathrin Schmeisser
Kathrin Schmeisser
DKDamla Kaptan
Damla Kaptan
BRBharath Kumar Raghuraman
Bharath Kumar Raghuraman
Andrej ShevchenkoAndrej Shevchenko
Andrej Shevchenko
SPSider Penkov
Sider Penkov
TKTeymuras V. Kurzchalia
Teymuras V. Kurzchalia
Recovery from the quiescent developmental stage called dauer is an essential process in C. elegans and provides an excellent model to understand how metabolic transitions contribute to developmental plasticity. We here show that the depletion of sterol-binding proteins SCL-12 and SCL-13 is the key change in the C. elegans proteome in early dauer recovery. This process releases a cholesterol store that is sequestered in the gut lumen during the dauer state to facilitate the transition into reproductive development. First, the stored cholesterol undergoes endocytosis into the lysosomes of the intestinal cells, where it activates mTOR to promote protein synthesis and growth. Second, it is used for the production of dafachronic acids that switch metabolic programs at the transcriptional level. These processes are essential for population fitness and survival, as loss of SCL-12 and SCL-13, depletion of sterols, and loss of mTOR precludes quiescence exit, ultimately leading to the expiration of the entire population.